...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Re: The 3 inflection points: SSRA, Top-Line, Full Data
1
Sep 08, 2018 01:57PM
2
Sep 08, 2018 03:12PM
1
Sep 08, 2018 05:02PM
1
Sep 08, 2018 05:27PM
1
Sep 08, 2018 05:48PM
3
Sep 08, 2018 08:59PM

Sep 08, 2018 10:38PM
4
Sep 09, 2018 08:33AM
8
Sep 09, 2018 11:22AM
6
Sep 09, 2018 01:36PM
4
Sep 09, 2018 07:40PM

Koo, 

You clearly didn't thoroughly read those top line data examples. The Jardiance/empagliflozin EMPA-REG Outcomes trial top line release did not state the 14% RRR. The full data release, including the 14% RRR statement came at the September 2015 EASD meeting, which came after the August 2015 top line data statement.

BearDownAZ 

Share
New Message
Please login to post a reply